Active Not Recruiting NA INTERVENTIONAL 3-arm NCT05937100

New Vital Pulpotomy Medications in Primary Molars

Clinical and Radiographic Evaluation of Hyaluronic Acid and Biodentine as Vital Pulpotomy Medications in Primary Molars: Randomized Controlled Clinical Trial

Sponsor: Mansoura University

Conditions Carious Exposure of Pulp

Interventions Biodentine Formocresol Hyaluronic acid gel

Updated 5 times since 2023 Last updated: May 25, 2025 Started: May 1, 2023 Primary completion: Jul 1, 2025 Completion: Aug 1, 2025

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Carious Exposure of Pulp, this trial is ongoing. The trial is conducted by Mansoura University and has accumulated 5 data snapshots since 2023. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2025 — Present [monthly]

Active Not Recruiting NA
Jun 2025 — Sep 2025 [monthly]

Active Not Recruiting NA
Sep 2024 — Jun 2025 [monthly]

Active Not Recruiting NA
Jul 2024 — Sep 2024 [monthly]

Active Not Recruiting NA
Aug 2023 — Jul 2024 [monthly]

Active Not Recruiting NA

First recorded

May 2023

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Mansoura University

Data source: Mansoura University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Al Mansurah, Egypt